Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
311.00    -14.00 (-4.31%)
Bid:
310.00
Ask:
312.00
Spread: 2.00 (0.645%)
Market Cap: £39.46m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Director dealing & appointment

29 May 2012 16:54

RNS Number : 3543E
BrainJuicer Group PLC
29 May 2012
 



 

 

 

 

Press Release

 29 May 2012

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Director Appointment and Director Dealing

 

BrainJuicer (AIM: BJU), a leading international online market research agency, announced on 23rd April 2012 that Simon Godfrey, a non-executive director of the Company, intends to retire from the board of directors by the end of September 2012.

 

He has been reducing his shareholding as a result, and the Company updates that Simon has today disposed of 10,000 shares at 308.50p per share. Following the above transaction, Simon currently holds 14,298 shares representing 0.1% of the voting rights of the Company.

 

As a replacement for Simon, the Board is appointing Graham Blashill (aged 65) as a non-executive director with effect from 1st July 2012. Graham has had a long career in sales and marketing of fast moving consumer goods. He joined W.D.& H.O. Wills (a division of Imperial Tobacco) in 1968, holding a number of marketing and trading roles, and becoming Managing Director Imperial Tobacco UK in 1995. In 2003 he was Regional Director for Western Europe, and in 2005 appointed Group Sales and Marketing Director responsible for Imperial Tobacco's global trading operations in over 160 countries. He served as a main board director of Imperial Tobacco Group plc, a leading FTSE 100 company, for six years before retiring in 2011.

 

Disclosures regarding Mr Blashill appointment, pursuant to AIM rules (Schedule 2 paragraph (g)), are set out below:

 

Directorships held within the last five years

 

·; Imperial Tobacco Group Plc

·; Imperial Tobacco Limited

·; Imperial Tobacco Overseas Holdings (3) Limited

·; Imperial Tobacco International Limited

·; Altadis S.A.U.

·; Skruf Snus AB

·; Societe Nationale D'explotation Industrielle Des Tabacs et Allumettes SAS (SEITA)

·; Imperial Tobacco Pension Trustees Limited

·; Tobacco Trade Benevolent Association

 

Current Directorships

 

·; Tobacco Pipe Makers and Tobacco Trade Benevolent Fund

 

There is no further information to be disclosed under AIM rules (Schedule 2 paragraph (g)) in respect of Mr Blashill's appointment.

 

The Company can be found at www.brainjuicer.com.

 

- Ends -

 

For further information, please contact:

BrainJuicer Group PLC

 

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000

 

James Geddes, Chief Financial Officer

www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor

Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGZKKLFGZZM
Date   Source Headline
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company
21st Sep 201811:56 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSAd Ratings and Trading Update
31st Aug 20185:02 pmRNSTotal Voting Rights
20th Aug 20187:00 amRNSHolding(s) in Company
17th Aug 20182:58 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSExercise of Options
26th Jul 20187:00 amRNSDirectorate Change
25th Jul 201812:04 pmRNSResult of AGM
24th Jul 20187:00 amRNSBoard Changes
10th Jul 20189:12 amRNSHolding(s) in Company
9th Jul 201811:31 amRNSHolding(s) in Company
2nd Jul 20183:50 pmRNSAnnual Report and Notice of AGM
28th Jun 20185:57 pmRNSHolding(s) in Company
12th Jun 20187:00 amRNSExercise of Options
11th Jun 20187:00 amRNSBoard Change
5th Jun 20184:31 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSDirector/PDMR Shareholding
4th Jun 20183:10 pmRNSDividend Declaration
1st Jun 20187:00 amRNSFinancial results to 31 March 2018
23rd May 20188:26 amRNSHolding(s) in Company
27th Apr 20184:30 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSTrading Update
9th Mar 20183:30 pmRNSTransaction in Own Shares
9th Mar 20187:00 amRNSExercise of Options and Buyback of Option Shares
8th Jan 20187:00 amRNSTrading Update
28th Nov 201711:52 amRNSHolding(s) in Company
27th Nov 20179:48 amRNSHolding(s) in Company
17th Nov 20177:00 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSTrading Update
2nd Oct 20174:26 pmRNSHolding(s) in Company
12th Sep 20172:31 pmRNSHolding(s) in Company
21st Aug 20175:49 pmRNSHolding(s) in Company
21st Aug 20177:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.